glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Table 2 from DPP- 4 Inhibitors in the Management of Type 2 Diabetes Mellitus GLP-1-RA and DPP-4 inhibitors in

An endogenous uncoupling and swelling agent in liver mitochondria and its enzymic formation

The result is mild water retention that shows up as puffiness in the hands, feet, or face

In people with T2D, retatrutide (0.5 to 12 mg) led to substantial reductions in bodyweight and HbA1c compared to both placebo and dulaglutide 1.5 mg in a phase 2 trial [67]

Key Benefits: Promotes skin brightening and reduces pigmentation

Lancet 372:146372 Dodd S, Maes M, Anderson G, Dean O, Moylan S, Berk M (2013) Putative neuroprotective agents in major psychoses

Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12